Cargando…
Clinical assessment of T2 papillary thyroid carcinoma: a retrospective study conducted at a single tertiary institution
The extent of surgery among patients with T2 papillary thyroid carcinoma (PTC) remains controversial. Thus, we herein aimed to evaluate the risk factors for recurrence, particularly based on the extent of surgery, among patients with T2 PTC at a single tertiary institution. We assessed 251 patients...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9360027/ https://www.ncbi.nlm.nih.gov/pubmed/35941209 http://dx.doi.org/10.1038/s41598-022-17979-2 |
_version_ | 1784764263229816832 |
---|---|
author | Kim, Hyesung Kim, Kwangsoon Bae, Ja Seong Kim, Jeong Soo |
author_facet | Kim, Hyesung Kim, Kwangsoon Bae, Ja Seong Kim, Jeong Soo |
author_sort | Kim, Hyesung |
collection | PubMed |
description | The extent of surgery among patients with T2 papillary thyroid carcinoma (PTC) remains controversial. Thus, we herein aimed to evaluate the risk factors for recurrence, particularly based on the extent of surgery, among patients with T2 PTC at a single tertiary institution. We assessed 251 patients who underwent thyroid surgery for T2 PTC from January 2009 to December 2014 at Seoul St. Mary’s Hospital (Seoul, Korea). The mean follow-up duration was 100.7 months. Eleven (4.4%) patients had recurrence. The recurrence rates did not significantly differ in terms of the extent of surgery (p = 0.868). Patients with a high lymph node ratio (LNR) had a significantly higher recurrence rate than those with a low LNR (p < 0.001). According to a recurrence pattern analysis, five of six patients in the lobectomy group had recurrence in the ipsilateral lateral compartment. A multivariate analysis revealed that a high LNR was a significant risk factor for recurrence (hazard ratio: 11.025, p = 0.002). Our results suggest that patients without clinical evidence of any lymph node metastases and those with limited lesions in the thyroid gland can undergo lobectomy and LNR can serve as an independent risk factor for predicting recurrence in T2 PTC. |
format | Online Article Text |
id | pubmed-9360027 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-93600272022-08-10 Clinical assessment of T2 papillary thyroid carcinoma: a retrospective study conducted at a single tertiary institution Kim, Hyesung Kim, Kwangsoon Bae, Ja Seong Kim, Jeong Soo Sci Rep Article The extent of surgery among patients with T2 papillary thyroid carcinoma (PTC) remains controversial. Thus, we herein aimed to evaluate the risk factors for recurrence, particularly based on the extent of surgery, among patients with T2 PTC at a single tertiary institution. We assessed 251 patients who underwent thyroid surgery for T2 PTC from January 2009 to December 2014 at Seoul St. Mary’s Hospital (Seoul, Korea). The mean follow-up duration was 100.7 months. Eleven (4.4%) patients had recurrence. The recurrence rates did not significantly differ in terms of the extent of surgery (p = 0.868). Patients with a high lymph node ratio (LNR) had a significantly higher recurrence rate than those with a low LNR (p < 0.001). According to a recurrence pattern analysis, five of six patients in the lobectomy group had recurrence in the ipsilateral lateral compartment. A multivariate analysis revealed that a high LNR was a significant risk factor for recurrence (hazard ratio: 11.025, p = 0.002). Our results suggest that patients without clinical evidence of any lymph node metastases and those with limited lesions in the thyroid gland can undergo lobectomy and LNR can serve as an independent risk factor for predicting recurrence in T2 PTC. Nature Publishing Group UK 2022-08-08 /pmc/articles/PMC9360027/ /pubmed/35941209 http://dx.doi.org/10.1038/s41598-022-17979-2 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Article Kim, Hyesung Kim, Kwangsoon Bae, Ja Seong Kim, Jeong Soo Clinical assessment of T2 papillary thyroid carcinoma: a retrospective study conducted at a single tertiary institution |
title | Clinical assessment of T2 papillary thyroid carcinoma: a retrospective study conducted at a single tertiary institution |
title_full | Clinical assessment of T2 papillary thyroid carcinoma: a retrospective study conducted at a single tertiary institution |
title_fullStr | Clinical assessment of T2 papillary thyroid carcinoma: a retrospective study conducted at a single tertiary institution |
title_full_unstemmed | Clinical assessment of T2 papillary thyroid carcinoma: a retrospective study conducted at a single tertiary institution |
title_short | Clinical assessment of T2 papillary thyroid carcinoma: a retrospective study conducted at a single tertiary institution |
title_sort | clinical assessment of t2 papillary thyroid carcinoma: a retrospective study conducted at a single tertiary institution |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9360027/ https://www.ncbi.nlm.nih.gov/pubmed/35941209 http://dx.doi.org/10.1038/s41598-022-17979-2 |
work_keys_str_mv | AT kimhyesung clinicalassessmentoft2papillarythyroidcarcinomaaretrospectivestudyconductedatasingletertiaryinstitution AT kimkwangsoon clinicalassessmentoft2papillarythyroidcarcinomaaretrospectivestudyconductedatasingletertiaryinstitution AT baejaseong clinicalassessmentoft2papillarythyroidcarcinomaaretrospectivestudyconductedatasingletertiaryinstitution AT kimjeongsoo clinicalassessmentoft2papillarythyroidcarcinomaaretrospectivestudyconductedatasingletertiaryinstitution |